Concord Drugs Ltd.
Snapshot View

33.45 +0.05 ▲0.2%

30 September 2022, 12:43:00 PM
Volume: 3,629

Overview View Details >>

Sector Healthcare Compare with Sector peers
Industry Pharmaceuticals & Drugs Compare with Industry peers
Website http://www.concorddrugs.in
Market Cap 29.51 Cr.
Enterprise Value(EV) 45.57 Cr. 2022-03
Financial Indicators
Earnings per share (EPS) 1.25 Trailing Twelve Months Ending 2022-06
Price-Earning Ratio (PE) 26.97 Trailing Twelve Months Ending 2022-06
Industry PE 31.29 Trailing Twelve Months Ending 2022-06
Book Value / Share 32.65 Trailing Twelve Months Ending 2022-06
Price to Book Value 1.03 Calculated using Price: 33.75
Dividend Yield 0.00 Period Ending 2021-03
No. of Shares Subscribed 0.87 Cr. 8,743,750 Shares
FaceValue 10
Company Profile
Concord Drugs is engaged in developing new products Viz MUPS (Multiple Unit Pellet System), Sustained Release, Modified Release pellets with Innovative Drug Delivery Technologies by utilizing best and latest processing machinery.

Delivery View Details >>

Delivered Qty
Traded Qty

Performance View Details >>

1 Day
+0.15%
1 Week
+3.08%
1 Month
+26.23%
3 Month
+18.41%
6 Month
+11.87%
1 Year
+1.67%
2 Year
+57.04%
5 Year
+19.04%
10 Year
9 years 2013-03 2014-03 2015-03 2016-03 2017-03 2018-03 2019-03 2020-03 2021-03
Return on Equity (%) 8.85 2.72 5.37 12.32 0.94 1.69 1.92 1.41 13.06
Return on Capital Employed (%) 6.30 7.15 11.33 15.90 8.84 7.49 6.17 6.06 15.69
Return on Assets (%) 2.93 0.79 1.41 3.28 0.30 0.40 0.43 0.47 6.08

Balance Sheet View Details >>

Particulars 10 years 2013-03 Rs. Cr. 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03* Rs. Cr.
Shh. Funds 14 15 13 15 19 19 23 23 27 28
Non Curr. Liab. 12 12 13 17 7 6 4 7 7 5
Curr. Liab. 15 18 28 21 29 81 56 27 16 23
Minority Int.
Equity & Liab. 41 45 54 52 56 106 83 58 50 56
Non Curr. Assets 20 21 19 16 25 14 13 12 14 15
Curr. Assets 21 23 36 37 30 92 70 46 36 42
Misc. Exp. not W/O
Total Assets 41 45 54 52 56 106 83 58 50 56

Profit Loss View Details >>

Particulars 10 years 2013-03 Rs. Cr. 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-06 Rs. Cr. TTM
Net Sales 28 34 40 51 57 52 48 51 51 51
Other Income 0 0 0 0 0 0 0 0
Total Income 28 34 40 51 58 52 48 51 51 51
Total Expenditure -26 -31 -33 -42 -52 -47 -44 -48 -48 -47
PBIDT 2 3 7 8 6 5 4 3 3 4
Interest -1 -2 -3 -3 -2 -2 -2 -2 -1 -1
Depreciation -1 -1 -4 -3 -3 -2 -2 -1 -1 -2
Taxation 0 0 0 -1 0 0 0 0 -1 -1
Exceptional Items 4
PAT 1 0 1 2 0 0 0 0 3 1
Adjusted EPS 1 0 1 2 0 0 1 0 4 1

Cash Flow View Details >>

Particulars 10 years 2012-03 Rs. Cr. 2013-03 Rs. Cr. 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr.
Cash Fr. Operatn. -3 1 2 2 4 2 7 1 2 2
Cash Fr. Inv. -2 -10 -2 -1 0 -1 -2 0 -1 -4
Cash Fr. Finan. 6 8 0 -1 -4 -4 -5 -1 -2 2
Net Change 0 -1 0 0 0 -3 0 0 0 0
Cash & Cash Eqvt 1 0 0 0 0 -3 0 0 0 0

Shareholding Pattern View Details >>

9 Qtrs 2020-06 (%) 2020-09 (%) 2020-12 (%) 2021-03 (%) 2021-06 (%) 2021-09 (%) 2021-12 (%) 2022-03 (%) 2022-06 (%)
Promoter 42.78 42.78 42.78 44.38 44.38 49.00 49.00 49.00 49.00
Public 57.22 57.22 57.22 55.62 55.62 51.00 51.00 51.00 51.00
Depository Receipts 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Promoter Holding Pledge (%) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

Announcements View Details >>

Thu, 08 Sep 2022
Reg. 34 (1) Annual Report.
Annual Report for the Financial Year 2021-22
Thu, 08 Sep 2022
Intimation Of Book Closure Dates For 27Th Annual General Meeting.
Register of Members and Share Transfer Books ofthe Company shall remain closed from 24.09.2022 to 30.09.2022 (both days inclusive) for the purpose of 27th Annual General Meeting of the Company.
Wed, 07 Sep 2022
Board Meeting Outcome for Outcome Of The Board Meeting
Outcome of the Board Meeting

Technical Scans View Details >>

Thu, 29 Sep 2022
High Delivery Percentage High Delivery Percentage
Higher Delivery Quantity Higher Delivery Quantity
Higher Delivery Quantity and Percentage Higher Delivery Quantity and Percentage
Higher Trade Quantity Higher Trade Quantity
Higher Trade and Delivery Quantity Higher Trade and Delivery Quantity

Related Stocks View Details >>

Stock Name Market Cap(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. 223,330.10 943.55 +1.4%
Divi's Laboratories Ltd. 97,819.86 3,710.60 +0.5%
Cipla Ltd. 90,339.79 1,117.80 +0.2%
Dr. Reddy's Laboratories Ltd. 72,565.89 4,332.00 -0.7%
Apollo Hospitals Enterprise Ltd. 63,143.03 4,387.45 -0.1%
Torrent Pharmaceuticals Ltd. 52,359.20 1,550.05 +0.3%
Abbott India Ltd. 40,610.60 19,160.60 -0.1%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-06 57.42 943.55 +1.4%
Divi's Laboratories Ltd. Consolidated 2022-06 31.50 3,710.60 +0.5%
Cipla Ltd. Consolidated 2022-06 36.30 1,117.80 +0.2%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-06 24.26 4,332.00 -0.7%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-06 71.47 4,387.45 -0.1%
Torrent Pharmaceuticals Ltd. Consolidated 2022-06 65.37 1,550.05 +0.3%
Abbott India Ltd. Standalone 2022-06 50.22 19,160.60 -0.1%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-06 4.46 943.55 +1.4%
Divi's Laboratories Ltd. Consolidated 2022-06 7.87 3,710.60 +0.5%
Cipla Ltd. Consolidated 2022-06 4.20 1,117.80 +0.2%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-06 3.58 4,332.00 -0.7%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-06 10.63 4,387.45 -0.1%
Torrent Pharmaceuticals Ltd. Consolidated 2022-06 8.19 1,550.05 +0.3%
Abbott India Ltd. Standalone 2022-06 13.62 19,160.60 -0.1%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 0.02 943.55 +1.4%
Divi's Laboratories Ltd. Consolidated 2022-03 0.00 3,710.60 +0.5%
Cipla Ltd. Consolidated 2022-03 0.04 1,117.80 +0.2%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 0.18 4,332.00 -0.7%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 0.47 4,387.45 -0.1%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 0.68 1,550.05 +0.3%
Abbott India Ltd. Standalone 2022-03 0.00 19,160.60 -0.1%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 943.55 +1.4%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 3,710.60 +0.5%
Cipla Ltd. Consolidated 2022-03 13.10 1,117.80 +0.2%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.55 4,332.00 -0.7%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,387.45 -0.1%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,550.05 +0.3%
Abbott India Ltd. Standalone 2022-03 29.95 19,160.60 -0.1%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 943.55 +1.4%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 3,710.60 +0.5%
Cipla Ltd. Consolidated 2022-03 13.10 1,117.80 +0.2%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.55 4,332.00 -0.7%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,387.45 -0.1%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,550.05 +0.3%
Abbott India Ltd. Standalone 2022-03 29.95 19,160.60 -0.1%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 38,654.49 943.55 +1.4%
Divi's Laboratories Ltd. Consolidated 2022-03 8,959.83 3,710.60 +0.5%
Cipla Ltd. Consolidated 2022-03 21,763.34 1,117.80 +0.2%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 21,545.20 4,332.00 -0.7%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 14,662.60 4,387.45 -0.1%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 8,508.04 1,550.05 +0.3%
Abbott India Ltd. Standalone 2022-03 4,919.27 19,160.60 -0.1%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 3,405.82 943.55 +1.4%
Divi's Laboratories Ltd. Consolidated 2022-03 2,960.45 3,710.60 +0.5%
Cipla Ltd. Consolidated 2022-03 2,559.47 1,117.80 +0.2%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 2,112.20 4,332.00 -0.7%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 1,101.10 4,387.45 -0.1%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 777.18 1,550.05 +0.3%
Abbott India Ltd. Standalone 2022-03 798.70 19,160.60 -0.1%

FAQ's On Concord Drugs Ltd.

What is Concord Drugs share price?

Can I buy Concord Drugs shares now?

What is the Market Cap of Concord Drugs?

What are the key metrics to analyse Concord Drugs?

What is the 52 Week High and Low of Concord Drugs?

What is the trend of Concord Drugs share price?